Today, I’m joined by Ariana Thacker, founder and CEO of MoldCo.
Born from personal experience, the company is revolutionizing treatment for mold-related illness by combining specialized testing, personalized protocols, and ongoing R&D.
In this episode, we discuss building a healthcare platform for mold toxicity.
We also cover:
- Mold exposure’s impact on 30–40M Americans
- Making the “Shoemaker Protocol” treatment more accessible
- Building a company that bridges care delivery with cutting-edge research
The Fitt Insider Podcast is brought to you by EGYM. Visit EGYM.com to learn more about its smart workout solutions for fitness and health facilities.
Chapters:
(00:00) Introduction
(01:40) Ariana’s journey to MoldCo
(03:20) Identifying mold exposure
(04:40) The prevalence of mold issues in homes and buildings
(06:00) Understanding mold toxicity symptoms and biomarkers
(07:40) The broken healthcare journey for mold patients
(10:20) Finding evidence-based solutions with the Shoemaker protocol
(12:40) Market size and impact
(14:40) From VC to founder
(18:20) Raising capital for an unconventional healthcare startup
(21:20) Growing mainstream awareness of environmental toxins
(23:20) Pioneering the standard of care for mold toxicity
(25:40) Using existing medications versus developing new treatments
(29:40) Expanding beyond mold
(32:00) Current operations and patient experience
(35:00) Nationwide expansion plans
(36:00) Making lab testing affordable and accessible
(37:40) Conclusion
